News | August 23, 2007

Report Says Skin-Ulcer Treatment Market to See New Growth

August 24, 2007 - The market for skin ulcer treatments is expected to see solid growth over the next four years due to demographic shifts and new treatments such as negative wound pressure therapy, sending the market to $6.2 billion in 2011, according to the third edition of "Wound Care Markets: Volume I: Skin Ulcers," a new report by New York-based Kalorama Information.
The report states overall steady growth in the worldwide skin ulcer treatment market will likely come from new therapies that result in decreasing healing times and subsequent cost savings; a growing focus on special populations such as diabetics and the obese; the increasing elderly population; availability of new therapeutic techniques; and the recent focus on wound care products and prevention.
Mature skin treatment products such as anti-infectives, skin ulcer management, and pressure relief devices will continue to generate the majority of sales, but advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. Additionally, negative pressure wound therapy — the use of vacuum pressure within a foam sponge and adhesive wrap which stimulates blood flow and promotes faster healing — is a segment expected to boost market sales with another dose of significant growth, estimated at 11.6 percent.
"Developments in treatments of skin ulcers have made tremendous strides in the last decade," said Mary Anne Crandall, author of the report. "New developments are providing the health care arena of today with some truly sophisticated, highly effective skin ulcer treatments. Revolutionary advances using tissue engineering, growth factors, animal-fetal-cell research, stem-cell research, and gene therapy may offer new hope to patients who experience acute and chronic skin ulcers."
"Wound Care Markets: Volume I: Skin Ulcers" covers the world wound care market for skin ulcers in the anti-infectives, skin ulcer management, moist dressings, negative pressure wound therapy, biological dressings, pressure relief, and miscellaneous treatments product segments. The report analyzes products in development and on the market, leading competitors, and current issues and trends.

For more information: www.KaloramaInformation.com.

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...